Amalgamated Bank’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,145
Closed -$10K 1779
2025
Q4
$10K Buy
2,145
+197
+10% +$953 ﹤0.01% 2406
2025
Q3
$10K Hold
1,948
﹤0.01% 2451
2025
Q2
$8K Hold
1,948
﹤0.01% 2514
2025
Q1
$5K Hold
1,948
﹤0.01% 2640
2024
Q4
$8K Hold
1,948
﹤0.01% 2523
2024
Q3
$6K Hold
1,948
﹤0.01% 2674
2024
Q2
$7K Hold
1,948
﹤0.01% 2594
2024
Q1
$6K Sell
1,948
-3,317
-63% -$10.2K ﹤0.01% 2627
2023
Q4
$19K Sell
5,265
-580
-10% -$1.67K ﹤0.01% 2664
2023
Q3
$15K Hold
5,845
﹤0.01% 2773
2023
Q2
$23K Hold
5,845
﹤0.01% 2668
2023
Q1
$20K Sell
5,845
-1,264
-18% -$5.15K ﹤0.01% 2642
2022
Q4
$25K Hold
7,109
﹤0.01% 2686
2022
Q3
$29K Hold
7,109
﹤0.01% 2684
2022
Q2
$32K Buy
+7,109
New +$51.3K ﹤0.01% 2680

Other funds holding SRTA

Amalgamated Bank's SRTA Position: Q1 2026 in Review

Amalgamated Bank sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 2,145 shares — an estimated $10K sold.

Amalgamated Bank first reported a position in SRTA in Q2 2022 and held it in 15 quarters. The position peaked at $32K in Q2 2022. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Amalgamated Bank reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,145 Strata Critical Medical Inc shares in Q1 2026, an estimated $10K.
  • Amalgamated Bank first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 15 quarters.
  • Amalgamated Bank's Strata Critical Medical Inc position peaked at $32K in Q2 2022.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.